HERG channels have been described to be up-regulated in a wide spectrum of hematopoietic malignancies like AML (~70%), CML, ALL or lymphomas, while it is not expressed during physiological hematopoietic development or in normal peripheral blood cells [30]. Here, KCNH2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.